Xolair subcutaneous injection 75mg syringe (YJ code: 2290400G1021, standard: 1 tube of 0.5mL 75mg) is a Novartis Pharma product containing Omalizumab (genetical recombination). It is used for severe allergic asthma in patients aged 6 years and older, chronic spontaneous urticaria in those 12 years and older, and chronic rhinosinusitis with nasal polyps in adults.
Xolair subcutaneous injection 75mg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →